Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Featured
Featured posts
Featured
Scribe Therapeutics reveals research collaboration with Sanofi to accelerate breakthrough CRISPR-based cell therapies for cancer
Tess Egginton
-
29th September 2022
0
APPROVALS
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type 1
Tess Egginton
-
29th September 2022
0
APPROVALS
Tezspire approved in Japan for the treatment of severe asthma
Tess Egginton
-
28th September 2022
0
Appointments
ACG appoints Shankar Gupta as chief sales officer
Tess Egginton
-
27th September 2022
0
APPROVALS
Bausch Health and Glenmark’s RYALTRIS approved in Canada for seasonal allergic rhinitis
Tess Egginton
-
27th September 2022
0
APPROVALS
Ultomiris approved in Europe for the treatment of adults with generalised myasthenia gravis
Tess Egginton
-
27th September 2022
0
Featured
Navigo and Mannin sign agreement to develop innovative affinity ligand against a novel drug for the treatment of COVID-19
Tess Egginton
-
27th September 2022
0
Featured
AVROBIO receives rare pediatric disease designation from U.S. FDA for first gene therapy in development for cystinosis
Tess Egginton
-
26th September 2022
0
APPROVALS
EC approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss
Tess Egginton
-
26th September 2022
0
EVENTS
Tower to bring the temperature of pharmaceutical logistics to CPhI
Tess Egginton
-
26th September 2022
0
1
2
3
...
42
Page 1 of 42
